# IKZF4

## Overview
IKZF4, also known as Eos, is a gene that encodes the IKAROS family zinc finger 4 protein, a transcription factor belonging to the Ikaros family of zinc finger proteins. This protein is characterized by its C2H2-type zinc finger motifs, which are crucial for its role in DNA binding and protein interactions. IKAROS family zinc finger 4 is primarily expressed in regulatory T cells (Tregs), where it plays a pivotal role in maintaining immune homeostasis by regulating gene expression through interactions with other transcription factors and chromatin remodeling proteins. The protein's ability to form complexes with other Ikaros family members and its involvement in chromatin structure modulation underscore its significance in immune cell function and development (Pan2009Eos; Powell2019Ikaros).

## Structure
IKZF4, also known as Eos, is a member of the Ikaros family of zinc finger transcription factors. The protein structure is characterized by two sets of highly conserved C2H2-type zinc finger motifs. The N-terminal zinc finger domains are responsible for binding to specific DNA sequences, particularly recognizing the sequence 'GGAAA' (John2011The; Powell2019Ikaros). The C-terminal zinc finger domains facilitate dimerization with itself or other family members, as well as interactions with other transcriptional regulators (John2011The; Powell2019Ikaros).

IKZF4 can undergo alternative splicing, resulting in multiple isoforms with varying functional properties (John2011The). Post-translational modifications, such as tyrosine phosphorylation, can affect the protein's cellular localization and function (John2011The). The zinc finger motifs are crucial for the protein's ability to bind DNA and interact with other proteins, which are key aspects of its function as a transcriptional regulator (John2011The).

While specific details on the primary, secondary, tertiary, or quaternary structure of IKZF4 are not provided, the general structural features of the Ikaros family, including IKZF4, are highlighted (Powell2019Ikaros).

## Function
IKZF4, also known as Eos, is a transcription factor that plays a critical role in the function of regulatory T cells (Tregs). It is a member of the Ikaros family of zinc finger proteins and is primarily expressed in Tregs, where it is essential for maintaining their suppressive function and immune homeostasis (Gokhale2019Selective; Pan2009Eos). Eos interacts directly with the transcription factor Foxp3, forming a complex that is crucial for Foxp3-dependent gene silencing. This interaction involves recruiting C-terminal binding protein 1 (CtBP1) to the promoter regions of target genes, leading to histone modifications and promoter methylation, which are necessary for selective gene silencing (Pan2009Eos).

In healthy cells, Eos is involved in maintaining the Treg signature and preventing the development of autoimmune diseases. Its absence or dysfunction can lead to a loss of Treg suppressive function, resulting in increased immune activation and autoimmunity (Gokhale2019Selective). Eos also plays a role in regulating the expression of interleukin-2 (IL-2) in Tregs, contributing to their suppressive capabilities (Powell2019Ikaros). Overall, Eos is crucial for the stability and function of Tregs, impacting immune tolerance and homeostasis.

## Clinical Significance
Mutations or alterations in the expression of the IKZF4 gene, also known as Eos, have significant clinical implications, particularly in the context of autoimmune diseases. The selective deletion of Eos in T-regulatory (Treg) cells leads to a loss of their suppressive function, resulting in systemic autoimmunity. This condition is characterized by increased activity of CD8+ T cells and elevated cytokine production, such as IFN-γ and TNF-α, which contribute to immune dysregulation (Gokhale2019Selective). Eos-deficient mice exhibit symptoms of systemic and organ-specific autoimmunity, including hyperglobulinemia, anti-nuclear antibodies, and lymphocyte infiltration in non-lymphoid organs (Gokhale2019Selective).

The absence of Eos also results in enhanced experimental autoimmune encephalomyelitis (EAE) and impaired immune regulation, as evidenced by increased T follicular helper cells and decreased T follicular regulatory cells (Gokhale2019Selective). These findings suggest that Eos is crucial for maintaining immune homeostasis, and its deficiency can lead to severe autoimmune conditions. The study highlights the potential for Eos as a target for therapeutic interventions in autoimmune diseases, given its role in modulating Treg function and preventing immune overactivation (Gokhale2019Selective).

## Interactions
IKZF4, also known as Eos, is a transcription factor that participates in various protein-protein and protein-DNA interactions. It is a member of the IKAROS family of zinc finger proteins, which are known for their role in regulating gene expression through DNA binding and interaction with other proteins. IKZF4 can form complexes with other members of the IKAROS family, which allows it to modulate gene expression in a coordinated manner. These interactions are crucial for its function in immune cell development and function.

IKZF4 is also known to interact with chromatin remodeling proteins. These interactions enable IKZF4 to influence the chromatin structure, thereby affecting the accessibility of DNA to transcriptional machinery. This ability to modulate chromatin structure is essential for its role in regulating the expression of genes involved in immune responses. Through these interactions, IKZF4 can either activate or repress the transcription of target genes, depending on the context and the specific proteins it interacts with.

The ability of IKZF4 to form multiprotein complexes and its interactions with chromatin remodeling proteins highlight its importance in the regulation of gene expression and its impact on immune cell function.


## References


[1. (John2011The) Liza B. John and Alister C. Ward. The ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Molecular Immunology, 48(9–10):1272–1278, May 2011. URL: http://dx.doi.org/10.1016/j.molimm.2011.03.006, doi:10.1016/j.molimm.2011.03.006. This article has 172 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2011.03.006)

[2. (Gokhale2019Selective) Ameya S. Gokhale, Arunakumar Gangaplara, Maria Lopez-Occasio, Angela M. Thornton, and Ethan M. Shevach. Selective deletion of eos (ikzf4) in t-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity. Journal of Autoimmunity, 105:102300, December 2019. URL: http://dx.doi.org/10.1016/j.jaut.2019.06.011, doi:10.1016/j.jaut.2019.06.011. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jaut.2019.06.011)

[3. (Pan2009Eos) Fan Pan, Hong Yu, Eric V. Dang, Joseph Barbi, Xiaoyu Pan, Joseph F. Grosso, Dinili Jinasena, Sudarshana M. Sharma, Erin M. McCadden, Derese Getnet, Charles G. Drake, Jun O. Liu, Michael C. Ostrowski, and Drew M. Pardoll. Eos mediates foxp3-dependent gene silencing in cd4 + regulatory t cells. Science, 325(5944):1142–1146, August 2009. URL: http://dx.doi.org/10.1126/science.1176077, doi:10.1126/science.1176077. This article has 371 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1176077)

[4. (Powell2019Ikaros) Michael D. Powell, Kaitlin A. Read, Bharath K. Sreekumar, and Kenneth J. Oestreich. Ikaros zinc finger transcription factors: regulators of cytokine signaling pathways and cd4+ t helper cell differentiation. Frontiers in Immunology, June 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.01299, doi:10.3389/fimmu.2019.01299. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.01299)